Cancer Patients Receiving Covid mRNA Shots Show Dramatically Longer Survival
Insurers Are Using Cancer Patients as Leverage
Common daily pill slashes colorectal cancer’s return by 55% | A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors returning after surgery.
